EMvision Medical (Australia) Performance
| EMV Stock | 1.89 0.04 2.07% |
The firm shows a Beta (market volatility) of -0.61, which means possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning EMvision Medical are expected to decrease at a much lower rate. During the bear market, EMvision Medical is likely to outperform the market. At this point, EMvision Medical Devices has a negative expected return of -0.078%. Please make sure to confirm EMvision Medical's skewness, accumulation distribution, and the relationship between the potential upside and kurtosis , to decide if EMvision Medical Devices performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days EMvision Medical Devices has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, EMvision Medical is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors. ...more
1 | Scott Kirkland Acquires 5 percent of EMvision Medical Devices - TipRanks | 09/10/2024 |
2 | EMvisions Director Acquires 200,000 Options - TipRanks | 11/19/2024 |
| Begin Period Cash Flow | 9.9 M |
EMvision |
EMvision Medical Relative Risk vs. Return Landscape
If you would invest 205.00 in EMvision Medical Devices on August 25, 2024 and sell it today you would lose (16.00) from holding EMvision Medical Devices or give up 7.8% of portfolio value over 90 days. EMvision Medical Devices is producing return of less than zero assuming 3.1237% volatility of returns over the 90 days investment horizon. Simply put, 27% of all stocks have less volatile historical return distribution than EMvision Medical, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
EMvision Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for EMvision Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as EMvision Medical Devices, and traders can use it to determine the average amount a EMvision Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.025
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | EMV |
Estimated Market Risk
| 3.12 actual daily | 27 73% of assets are more volatile |
Expected Return
| -0.08 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.02 actual daily | 0 Most of other assets perform better |
Based on monthly moving average EMvision Medical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of EMvision Medical by adding EMvision Medical to a well-diversified portfolio.
EMvision Medical Fundamentals Growth
EMvision Stock prices reflect investors' perceptions of the future prospects and financial health of EMvision Medical, and EMvision Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on EMvision Stock performance.
| Return On Equity | -0.23 | ||||
| Return On Asset | -0.0795 | ||||
| Profit Margin | (0.24) % | ||||
| Operating Margin | (0.56) % | ||||
| Current Valuation | 148.67 M | ||||
| Shares Outstanding | 85.52 M | ||||
| Price To Book | 8.89 X | ||||
| Price To Sales | 14.33 X | ||||
| Revenue | 11.22 M | ||||
| Gross Profit | 6.97 M | ||||
| EBITDA | (2.09 M) | ||||
| Net Income | (2.73 M) | ||||
| Total Debt | 2.9 M | ||||
| Book Value Per Share | 0.22 X | ||||
| Cash Flow From Operations | (5.99 M) | ||||
| Earnings Per Share | (0.03) X | ||||
| Total Asset | 23.97 M | ||||
| Retained Earnings | (26.52 M) | ||||
About EMvision Medical Performance
Assessing EMvision Medical's fundamental ratios provides investors with valuable insights into EMvision Medical's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the EMvision Medical is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
EMvision Medical is entity of Australia. It is traded as Stock on AU exchange.Things to note about EMvision Medical Devices performance evaluation
Checking the ongoing alerts about EMvision Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for EMvision Medical Devices help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| EMvision Medical generated a negative expected return over the last 90 days | |
| EMvision Medical may become a speculative penny stock | |
| EMvision Medical has high historical volatility and very poor performance | |
| The company reported the revenue of 11.22 M. Net Loss for the year was (2.73 M) with profit before overhead, payroll, taxes, and interest of 6.97 M. | |
| EMvision Medical generates negative cash flow from operations | |
| About 36.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: EMvisions Director Acquires 200,000 Options - TipRanks |
- Analyzing EMvision Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether EMvision Medical's stock is overvalued or undervalued compared to its peers.
- Examining EMvision Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating EMvision Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of EMvision Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of EMvision Medical's stock. These opinions can provide insight into EMvision Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for EMvision Stock Analysis
When running EMvision Medical's price analysis, check to measure EMvision Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EMvision Medical is operating at the current time. Most of EMvision Medical's value examination focuses on studying past and present price action to predict the probability of EMvision Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EMvision Medical's price. Additionally, you may evaluate how the addition of EMvision Medical to your portfolios can decrease your overall portfolio volatility.